Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 425 clinical trials
Featured trial
Multiple Sclerosis

LIVING WITH MULTIPLE SCLEROSIS?The purpose of this study is to find out the effect of the study drug, on the body in patients with MS by assessing your

spasticity
  • 0 views
  • 28 Oct, 2021
  • 1 location
Featured trial
A research study for patients who have been diagnosed with multiple sclerosis

A research study for patients who have been diagnosed with multiple sclerosis

  • 380 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A research study for patients who have been diagnosed with multiple sclerosis

A research study for patients who have been diagnosed with multiple sclerosis

dimethyl fumarate
  • 807 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Verismo: AN OBSERVATIONAL STUDY OF OCRELIZUMAB-TREATED PATIENTS WITH MULTIPLE SCLEROSIS TO DETERMINE THE INCIDENCE AND MORTALITY RATES OF BREAST CANCER AND ALL MALIGNANCIES

The purpose of this study is to obtain additional safety information on OCREVUS® and to gain insights about how well OCREVUS® is tolerated by patients to whom it is prescribed in routine practice.

ocrelizumab
  • 0 views
  • 08 Jan, 2022
  • 1 location
Featured trial
Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis

Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis

  • 377 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

  • 362 views
  • 08 Nov, 2020
  • 1 location
Featured trial
An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing

  • 185 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis

A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis

  • 204 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis

A Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis

  • 134 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (OPTIMUM)

Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple

  • 284 views
  • 08 Nov, 2020
  • 1 location